The COVID-19 special medicine sector rose sharply during the session, and Guangshengtang hit the daily limit
2024-08-12
한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina
On August 12, the COVID-19 special medicine sector rose sharply during the trading session. As of press time, Guangshengtang hit its daily limit, Shutaishen rose by more than 11%, and Xinhua Pharmaceutical, Yaben Chemical, Zhongsheng Pharmaceutical and others were among the top gainers.
On the news front, the Guangdong Provincial Bureau of Disease Control and Prevention released an overview of the province's statutory infectious disease epidemics in June and July 2024, showing that the number of new coronavirus infections in Guangdong Province was 8,246 in June and 18,384 in July, an increase of more than 10,000 cases.
According to the Chinese Center for Disease Control and Prevention, from July 1 to 31, 203 new severe cases of COVID-19 infection and 2 deaths were reported in 31 provinces (autonomous regions, municipalities) and the Xinjiang Production and Construction Corps.
According to the "Huashan Infection" WeChat official account, Professor Zhang Wenhong, director of the National Center for Infectious Diseases and director of the Department of Infectious Diseases at Huashan Hospital Affiliated to Fudan University, analyzed that global new coronavirus infections have entered a similar volatility range.
Zhang Wenhong mentioned that the periodic fluctuations are related to the mutation of the virus and the fluctuations in the strength of the immune barrier. According to the current monitoring results of the three new crown fluctuations in May, August 2023 and February 2024, due to the continuous mutation of the virus and the phased attenuation of the immune barrier, the new coronavirus has become similar to respiratory infectious diseases such as influenza, and has gradually become a respiratory disease that is prevalent in my country, but the severity of the disease has remained relatively stable.
(This article comes from China Business Network)
